Previous studies have reported that tumours derived from xenotransplanted CD133- glioma cells have been shown to contain large proportions of CD133+ cells, suggesting that while CD133 expression is not necessary for oncogenesis it may be important for tumour progression [70]. The gene discussed is PROM1; the disease is central nervous system cancer.